|
QuintilesIMS Real-World Insights Bibliography
| Quantification of patient preference analysis_Wearing the federal joint committee lens to assess evidence |
| Author(s): Gaba D1, Eheberg D, Bonduelle D |
| Affiliations(s): 1 Quintiles IMS, Gurgaon, India 2 QuintilesIMS, Munich, Germany |
| Publication(s): |
| Document Type(s): Poster |
| Countries: Germany, India |
C: Y: |
Health status & patient reported outcomes, Pricing and reimbursement 2016 |
|
L: A: |
English Pricing & Reimbursement |
|
|
| |
| |
| Market uptake of direct oral anticoagulants (DOACS) in germany |
| Author(s): Batscheider A1, Greese B1, Dannemann S1, Gaba D2, Paulus G1, Stöcker P1, Greiner R1 |
| Affiliations(s): 1 QuintilesIMS, Munich, Germany 2 QuintilesIMS, Gurgaon, India |
| Publication(s): |
| Document Type(s): Poster |
| Countries: Germany, India |
C: Y: |
Cardiovascular disease 2016 |
|
L: A: |
English Market impact |
|
|
| |
| |
| USAGE OF SELF-MONITORING OF BLOOD GLUCOSE (SMBG) BY DIABETES THERAPY TYPE IN INDIA. |
| Author(s): Mast O1, Tan A2, Punjabi K3 |
| Affiliations(s): 1Roche Diagnostics, Diabetes Care, Mannheim, Germany, 2Cegedim Strategic Data, Singapore, Singapore, 3Cegedim Strategic Data, Mumbai, India |
| Publication(s): ISPOR 17th Annual European Congress
Amsterdam, The Netherlands
November, 2014 |
| Document Type(s): Poster |
| Countries: India |
| Click here for the abstract |
C: Y: |
Diabetes 2014 |
|
L: A: |
English
|
|
|
| |
| |
| Direct Medical Costs Of Diabetes-Related Complications In India |
| Author(s): Todorova L1, Hnoosh A2, Korde G3, Shiu ML4 |
| Affiliations(s): 1 Novo Nordisk International Operations, Zurich, Switzerland, 2 IMS Health, London, UK, 3 IMS Health Consulting Group, Mumbai, India, 4 Novo Nordisk Pharma Operations (BAOS) Sdn. Bhd., Kuala Lumpur, Malaysia |
| Publication(s): ISPOR 5th Asia-Pacific Conference, 2-4 September 2012, Taipei, Taiwan. |
| Document Type(s): Abstract |
| Countries: India |
| Click here for the abstract |
C: Y: |
Diabetes 2012 |
|
L: A: |
English Cost analysis |
|
|
| |
| |
| The cost-effectiveness of travoprost preserved with polyquad® in newly treated open-angle glaucoma patients in 7 Asian countries. |
| Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3 |
| Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore |
| Publication(s): 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan |
| Document Type(s): Abstract, Poster |
| Countries: India, Malaysia, Singapore, South Korea, Thailand |
C: Y: |
Ophthalmology 2012 |
|
L: A: |
English Cost effectiveness |
|
|
| |
| |
| Medical resource use and associated costs in open-angle glaucoma in 10 Asia-pacific countries. |
| Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3 |
| Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore |
| Publication(s): 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan |
| Document Type(s): Abstract, Poster |
| Countries: Australia, China, Hong Kong, India, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand |
C: Y: |
Ophthalmology 2012 |
|
L: A: |
English Burden of illness |
|
|
| |
| |
|
|
|